REQUEST A DEMO
Total
USD $0.00
Search more companies

Herba Drug Int., Spol. S R.O. (Czech Republic)

Main Activities: Wholesale Trade
Full name: Herba Drug Int., Spol. S R.O. Profile Updated: April 16, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Herba Drug Int., Spol. S R.O. is a company based in Czech Republic, with its head office in Vracov. It operates in the Wholesale Trade sector. It was incorporated on December 02, 1998. There are currently 1 - 5 (2023) people employed by Herba Drug Int., Spol. S R.O.. From the latest financial highlights, Herba Drug Int., Spol. S R.O. reported a net sales revenue drop of 11.83% in 2025. Its’ total assets recorded a growth of 28.56%. The net profit margin of Herba Drug Int., Spol. S R.O. decreased by 1.86% in 2025.

Headquarters
Borova 1710
Vracov; Jihomoravsky; Postal Code: 69642

Contact Details: Purchase the Herba Drug Int., Spol. S R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Herba Drug Int., Spol. S R.O. report to view the information.
Registered Capital:
Purchase the Herba Drug Int., Spol. S R.O. report to view the information.
Financial Auditors:
Purchase the Herba Drug Int., Spol. S R.O. report to view the information.
Incorporation Date:
December 02, 1998
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Herba Drug Int., Spol. S R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-11.83%
Total Operating Revenue
-11.83%
Operating Profit
-83.7%
EBITDA
-83.7%
Net Profit/Loss for the Period
-84.37%
Total Assets
28.56%
Total Equity
3.44%
Operating Profit Margin
-2.36%
Net Profit Margin
-1.86%
Return on Equity (ROE)
-18.68%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?